TOS/NORC Joint Symposium: Beyond the GLP-1 Era - How Far Can We Leverage the Gut-Brain Axis?
When: Monday, 11/4/2024, 10:00 am - 11:30 am
Where: Henry B. Gonzalez Convention Center-006
Description: Some people respond remarkably well to the newest weight loss medications, losing substantial weight at even the lowest doses. However, others do not lose substantial weight at all despite adhering closely to these new medications. Still others cannot tolerate these medications due to profound gastrointestinal symptoms. What accounts for this immense heterogeneity, and what more must be learned about the gut-brain axis to explain this? Exploring the wider spectrum of gut derived inputs that impact the brain to control hunger, satiety, and energy balance is essential if we are to expand the array of effective approaches to lower excess body weight for those who need it and move beyond the current GLP-1 era and into an even more widely effective future one.

This session is a joint collaboration between The Obesity Society (TOS) and Nutrition Obesity Research Centers (NORC).
Keyword: Cell/Organ Processes: Nutrient Sensing; Energy Balance: Appetite/Hunger/Satiety; Organ/System Specific: Gut/Brain Axis
Track: Sub-track: Obesity Medicine Exam Prep; Track 2: Neuroscience
Speakers:
Suneil Koliwad, MD, PhDSession Chair
Will de Lartigue, PhDRebooting the Gut-Brain Connection: Harnessing Its Power to Combat Obesity10:00 am - 10:20 am
Alice Adriaenssens, PhDGIPR in the CNS: New Insights, New Questions10:20 am - 10:40 am
Martin Valdearcos, PhDMicroglia at the Crossroads of Gut-Brain Signaling in Metabolic Regulation10:40 am - 11:00 am
Philipp E. Scherer, PhDNovel Aspects of the Adipocyte/GIPR Brain Axis11:00 am - 11:20 am
Suneil Koliwad, MD, PhDModerate Panel Q&A11:20 am - 11:30 am
Philipp E. Scherer, PhDPanel Q&A11:20 am - 11:30 am
Martin Valdearcos, PhDPanel Q&A11:20 am - 11:30 am
Alice Adriaenssens, PhDPanel Q&A11:20 am - 11:30 am
Will de Lartigue, PhDPanel Q&A11:20 am - 11:30 am
Learning Objective: Understand the evidence-based science regarding neuroendocrine, endocrine, microbiota and cognitive mechanisms regulating energy balance and body weight. Apply that knowledge to develop and implement treatment options for adults and pediatric patients with overweight, obesity or obesity-related co-morbidities.